Literature DB >> 16052038

Opioid receptors and their interacting proteins.

Graeme Milligan1.   

Abstract

The opioid receptors are among the most highly studied members of the family of G protein-coupled receptors. As for many other members of this family, recent studies have indicated that they do not exist in isolation but are able to interact with a substantial range of other polypeptides. Such interactions can alter the effectiveness of agonist-mediated cell signalling, determine the signals generated, alter the intracellular trafficking routes of the receptors and potentially determine cellular localization by providing a scaffold to link the receptors to the cytoskeletal network. Although virtually all studies on these interactions to date have employed expression into simple heterologous cell lines, the availability of knock-out mouse lines and the capacity to knock-down levels of opioid receptor-interacting proteins using techniques such as siRNA suggest that information on the functional consequences of such protein-protein interactions in a physiological setting will soon be forthcoming.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052038     DOI: 10.1385/NMM:7:1-2:051

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   4.103


  62 in total

1.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties.

Authors:  S R George; T Fan; Z Xie; R Tse; V Tam; G Varghese; B F O'Dowd
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

2.  Localization and enhanced current density of the Kv4.2 potassium channel by interaction with the actin-binding protein filamin.

Authors:  K Petrecca; D M Miller; A Shrier
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

Review 3.  Opioid receptors and their ligands.

Authors:  Anna Janecka; Jakub Fichna; Tomasz Janecki
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

4.  Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate.

Authors:  Jian-Guo Li; Chongguang Chen; Lee-Yuan Liu-Chen
Journal:  J Biol Chem       Date:  2002-05-09       Impact factor: 5.157

5.  Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.

Authors:  L M Bohn; R R Gainetdinov; F T Lin; R J Lefkowitz; M G Caron
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

6.  Calmodulin regulation of basal and agonist-stimulated G protein coupling by the mu-opioid receptor (OP(3)) in morphine-pretreated cell.

Authors:  D Wang; C K Surratt; W Sadée
Journal:  J Neurochem       Date:  2000-08       Impact factor: 5.372

7.  A relationship between protein kinase C phosphorylation and calmodulin binding to the metabotropic glutamate receptor subtype 7.

Authors:  Y Nakajima; T Yamamoto; T Nakayama; S Nakanishi
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

8.  Fluorescence studies of the location and membrane accessibility of the palmitoylation sites of rhodopsin.

Authors:  S J Moench; J Moreland; D H Stewart; T G Dewey
Journal:  Biochemistry       Date:  1994-05-17       Impact factor: 3.162

9.  Binding of filamin to the C-terminal tail of the calcitonin receptor controls recycling.

Authors:  Thomas Seck; Roland Baron; William C Horne
Journal:  J Biol Chem       Date:  2003-01-16       Impact factor: 5.157

10.  Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons.

Authors:  Ning Zhang; Thomas J Rogers; Michael Caterina; Joost J Oppenheim
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

View more
  14 in total

1.  Opiate agonist-induced re-distribution of Wntless, a mu-opioid receptor interacting protein, in rat striatal neurons.

Authors:  B A S Reyes; K Vakharia; T N Ferraro; R Levenson; W H Berrettini; E J Van Bockstaele
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

Review 2.  Theoretical considerations on the topological organization of receptor mosaics.

Authors:  Agnati Luigi Francesco; Fuxe Kjell; Woods Amina; Genedani Susanna; Guidolin Diego
Journal:  Curr Protein Pept Sci       Date:  2009-12       Impact factor: 3.272

3.  Association study of the β-arrestin 2 gene (ARRB2) with opioid and cocaine dependence in a European-American population.

Authors:  Lisa M Ambrose-Lanci; Meera Vaswani; Toni-Kim Clarke; Angela Zeng; Falk W Lohoff; Thomas N Ferraro; Wade H Berrettini
Journal:  Psychiatr Genet       Date:  2012-06       Impact factor: 2.458

4.  Morphine-induced trafficking of a mu-opioid receptor interacting protein in rat locus coeruleus neurons.

Authors:  Kellie M Jaremko; Nicholas L Thompson; Beverly A S Reyes; Jay Jin; Brittany Ebersole; Christopher B Jenney; Patricia S Grigson; Robert Levenson; Wade H Berrettini; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-12-12       Impact factor: 5.067

5.  Ultrastructural relationship between the mu opioid receptor and its interacting protein, GPR177, in striatal neurons.

Authors:  Arith-Ruth S Reyes; Robert Levenson; Wade Berrettini; Elisabeth J Van Bockstaele
Journal:  Brain Res       Date:  2010-09-21       Impact factor: 3.252

Review 6.  Molecular mechanisms of opioid receptor-dependent signaling and behavior.

Authors:  Ream Al-Hasani; Michael R Bruchas
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

7.  Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence.

Authors:  Jay Jin; Saranya Kittanakom; Victoria Wong; Beverly A S Reyes; Elisabeth J Van Bockstaele; Igor Stagljar; Wade Berrettini; Robert Levenson
Journal:  BMC Neurosci       Date:  2010-03-09       Impact factor: 3.288

8.  Case-control association study of WLS variants in opioid and cocaine addicted populations.

Authors:  Richard C Crist; Lisa M Ambrose-Lanci; Angela Zeng; Cindy Yuan; Kyle M Kampman; Helen M Pettinati; David W Oslin; Charles P O'Brien; Thomas N Ferraro; Glenn A Doyle; Falk W Lohoff; Wade H Berrettini
Journal:  Psychiatry Res       Date:  2013-04-05       Impact factor: 3.222

9.  Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations.

Authors:  R C Crist; L M Ambrose-Lanci; M Vaswani; T K Clarke; A Zeng; C Yuan; T N Ferraro; H Hakonarson; K M Kampman; C A Dackis; H M Pettinati; C P O'Brien; D W Oslin; G A Doyle; F W Lohoff; W H Berrettini
Journal:  Drug Alcohol Depend       Date:  2012-07-12       Impact factor: 4.492

Review 10.  Modulation of opioid receptor function by protein-protein interactions.

Authors:  Konstantinos Alfaras-Melainis; Ivone Gomes; Raphael Rozenfeld; Venetia Zachariou; Lakshmi Devi
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.